Table I.
MMP/E-cad Ratio | ||||||
---|---|---|---|---|---|---|
Reviewer | GS | N | Peripheral | P-value | Central | P-value |
1 | 6 | 7 | 2.09 (1.09)
(0.96, 3.73) |
2.63 (1.27)
(0.95, 4.76) |
||
7 | 16 | 3.62 (2.20)
(0.86, 9.83) |
2.30 (0.92)
(0.94, 3.99) |
|||
8 | 8 | 7.04 (4.69)
(0.77, 15.98) |
2.44 (1.08)
(0.59, 3.98) |
|||
9 | 5 | 6.39 (2.54)
(3.25, 9.04) |
0.02 |
3.78 (3.34)
(1.11, 9.36) |
0.88 |
|
2 | 6 | 7 | 1.56 (0.49)
(0.75, 2.20) |
1.21 (0.47)
(0.49, 1.84) |
||
7 | 16 | 2.24 (1.33)
(0.74, 5.32) |
1.37 (0.46)
(0.61, 2.38) |
|||
8 | 8 | 5.16 (3.47)
(2.38, 13.22) |
2.64 (1.57)
(1.22, 6.14) |
|||
9 | 5 | 3.46 (0.61)
(2.61, 4.25) |
0.0008 |
1.42 (0.58)
(0.91, 2.35) |
0.02 |
Results represent the mean (SD) of the maximum values for each tumor and the range. M/E, matrix metalloproteinase to E-cadherin; ISH, in situ hybridization; GS, Gleason score; N, number.